NAD+
NMN vs NAD+ IV Therapy: Which is Better for Cellular Aging?
NAD+ IV therapy is expensive, inconvenient, and creates temporary spikes rather than sustainable cellular support. Daily Liposomal NMN provides the precursor your cells use to build their own NAD+ continuously, while PQQ triggers the creation of entirely new mitochondria. Together they address cellular energy production from two distinct angles, building the kind of metabolic foundation that periodic IV treatments can never replicate long term.